Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM ...Middle East

CHENGDU, China , Oct. 19, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3 OptiTROP-Lung04 trial of the Company's...

Hence then, the article about positive results from phase 3 optitrop lung04 trial of sacituzumab tirumotecan presented at esmo presidential symposium and simultaneously published in nejm was published today ( Monday 20/10/2025 - 05:07 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM )

Also on site :

• Disgraced former Centinela Valley schools Superintendent Jose Fernandez dies
• Tyler Perry Sued for Sexual Assault By New Accuser, an Actor in a ‘Madea’ Movie
• New law revives dormant plans for solar plant near Mojave National Preserve